Recombinant Human IL34, N-His

Description of Recombinant Human IL34, N-His

Introduction to Recombinant Human IL34

Recombinant Human IL34, also known as Interleukin-34, is a cytokine that plays a crucial role in the immune system. It is a protein produced by recombinant DNA technology, making it a valuable tool in the field of biotechnology and medicine. In this article, we will explore the structure, activity, and application of Recombinant Human IL34.

Structure of Recombinant Human IL34

Recombinant Human IL34 is a glycoprotein consisting of 242 amino acids with a molecular weight of approximately 39 kDa. It is primarily produced by monocytes, macrophages, and dendritic cells, and is encoded by the IL34 gene located on chromosome 16. The protein has a conserved structure, with a single alpha-helical bundle domain and four cysteine residues that form two disulfide bonds. These structural features are essential for the biological activity of IL34.

Activity of Recombinant Human IL34

Recombinant Human IL34 is a potent cytokine that acts as a ligand for the colony-stimulating factor 1 receptor (CSF1R). This receptor is expressed on the surface of various immune cells, including monocytes, macrophages, and dendritic cells. Upon binding to CSF1R, IL34 activates signaling pathways that promote cell survival, proliferation, and differentiation. This results in the production of immune cells that play a crucial role in the body’s defense against infections and diseases.

Moreover, IL34 also has a role in regulating the function of microglia, the immune cells of the central nervous system. It promotes the survival and differentiation of microglia, which are essential for maintaining the health of the brain and spinal cord. Additionally, studies have shown that IL34 can stimulate the production of osteoclasts, the cells responsible for bone resorption. This activity of IL34 makes it a potential target for the treatment of bone disorders such as osteoporosis.

Applications of Recombinant Human IL34

Recombinant Human IL34 has various applications in the fields of biotechnology and medicine. One of its primary uses is in the production of immune cells for research purposes. By stimulating the differentiation of monocytes and macrophages, IL34 can be used to generate a large number of these cells for in vitro studies. This has been particularly useful in studying the role of macrophages in various diseases and developing new therapeutic strategies.

Moreover, the unique activity of IL34 in regulating microglia function makes it a potential therapeutic target for neurological disorders such as Alzheimer’s disease and multiple sclerosis. Research has shown that blocking IL34 signaling can reduce inflammation and improve cognitive function in animal models of these diseases. This has led to the development of potential IL34-based therapies for these conditions.

In addition, the ability of IL34 to stimulate osteoclast production has made it a promising candidate for the treatment of bone disorders. Recombinant Human IL34 has been used in preclinical studies to promote bone regeneration and repair in animal models of osteoporosis and bone fractures. These promising results have paved the way for further research and clinical trials to explore the potential of IL34 in treating bone-related conditions.

Conclusion

In conclusion, Recombinant Human IL34 is a valuable protein with a wide range of applications in biotechnology and medicine. Its unique structure and potent activity make it an essential tool for studying the immune system and developing new therapeutic strategies. With ongoing research and clinical trials, the potential of IL34 in treating various diseases and disorders continues to expand, making it an exciting area of study in the field of immunology.